Belimumab in Lupus Nephritis REPLY

被引：2
|
作者：
Furie, Richard [1 ]
Rovin, Brad H. [2 ]
Roth, David A. [3 ]
机构：
[1] Northwell Hlth, Great Neck, NY 11021 USA
[2] Ohio State Univ, Columbus, OH 43210 USA
[3] GlaxoSmithKline, Collegeville, PA USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2021年 / 384卷 / 02期
关键词：
D O I：
10.1056/NEJMc2032520
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：188 / 188
页数：1
相关论文
共 50 条
  • [41] Treatment of Lupus Nephritis with Belimumab Is Associated with Reduction in Urinary CD23
    Weeding, Emma
    Fava, Andrea
    Mohan, Chandra
    Goldman, Daniel
    Petri, Michelle
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3617 - 3619
  • [42] Discontinuation of therapy in lupus nephritis reply
    Malvar, Ana
    Rovin, Brad H.
    KIDNEY INTERNATIONAL, 2020, 97 (04) : 807 - 807
  • [43] Thrombotic microangiopathy with refractory lupus nephritis successfully treated by combining rituximab with belimumab
    Hanai, S.
    Kobayashi, Y.
    Ito, R.
    Harama, K.
    Nakagomi, D.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2023, 52 (02) : 227 - 229
  • [44] Biological sequential therapy with rituximab-belimumab in patients with recurrent lupus nephritis
    Robles-Marhuenda, Angel
    Cobo-Ibanez, Tatiana
    Noblejas-Mozo, Ana
    Munoz-Fernandez, Santiago
    REUMATOLOGIA CLINICA, 2023, 19 (05): : 290 - 291
  • [45] Efficacy and safety of belimumab combined with the standard regimen in treating children with lupus nephritis
    Li, Huarong
    Chen, Chaoying
    Yang, Hongxian
    Tu, Juan
    EUROPEAN JOURNAL OF PEDIATRICS, 2024, 183 (09) : 3987 - 3995
  • [46] The Cost-Effectiveness of Belimumab and Voclosporin for Patients with Lupus Nephritis in the United States
    Mandrik, Olena
    Fotheringham, James
    Ren, Shijie
    Tice, Jeffrey A.
    Chapman, Richard H.
    Stevenson, Matthew D.
    Pearson, Steven D.
    Herron-Smith, Serina
    Agboola, Foluso
    Thokala, Praveen
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (03): : 385 - 394
  • [47] Extrapolation of the Efficacy and Pharmacokinetics of Belimumab to Support its Use in Children with Lupus Nephritis
    Dimelow, Richard
    Liefaard, Lia
    Green, Yulia
    Tomlinson, Ryan
    CLINICAL PHARMACOKINETICS, 2024, 63 (09) : 1313 - 1326
  • [48] Effect of belimumab in renal function and proteinuria in patients with lupus nephritis (LN): our experience
    Liebana, Marc Patricio
    Romeo, Maria Jose Soler
    Hernandez, Josefina Cortes
    Gabaldon, Maria Alejandra
    Carrillo, Jorge Ivan Zamora
    Lopez, Marina
    Borda, Jhusel Rosas
    Garcia, Sheila Bermejo
    Berna, Gerson
    Leon, Juan Carlos
    Matamoros, Oriol Bestard
    Pamplona, Irene Agraz
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [49] COST-EFFECTIVENESS ANALYSIS OF BELIMUMAB FOR THE TREATMENT OF ADULTS WITH ACTIVE LUPUS NEPHRITIS IN CHINA
    Wu, B.
    He, X.
    Tang, Z.
    Martin, A.
    Bracher, M.
    Guo, N.
    Campbell, K.
    VALUE IN HEALTH, 2024, 27 (06) : S77 - S77
  • [50] Case report: successful treatment of membranous lupus nephritis with belimumab in an African female immigrant
    De Scheerder, Marie-Angelique
    Boey, O.
    Mahieu, E.
    Vanuytsel, J.
    Bogaert, Anne-Marie
    CLINICAL RHEUMATOLOGY, 2016, 35 (06) : 1649 - 1653
12345